Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ampio Pharmaceuticals Inc market cap is $207,884.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ampio Pharmaceuticals Inc 52 week high is $0.6435 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ampio Pharmaceuticals Inc 52 week low is $0.0052 as of November 21, 2026.
Ampio Pharmaceuticals Inc stock price today is $0.1831.
Ampio Pharmaceuticals Inc stock price yesterday was $0.64.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ampio Pharmaceuticals Inc 50-day moving average is $0.1831.